Related Experiment Video
Updated: Feb 25, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Changing concepts in hypertension management
P S Gudsoorkar1,2, S W Tobe3
1Department of Medicine, Clinical Fellow Adult Renal Transplant, Multi Organ Transplant Program, University Health Network, Toronto, ON, Canada.
Insights
New hypertension guidelines, informed by SPRINT and HOPE-3 trials, emphasize automated blood pressure measurement and impact treatment targets, especially for resistant hypertension.
Area of Science:
- Cardiology
- Clinical Practice Guidelines
- Hypertension Management
Background:
- Hypertension is a primary modifiable risk factor for cardiovascular disease (CVD) and mortality.
- Antihypertensive medications reduce target organ damage and prevent CVD events.
- Recent trials like SPRINT and HOPE-3 are poised to influence clinical practice.
Purpose of the Study:
- To review recent hypertension trials, including SPRINT and HOPE-3.
- To contextualize these findings within existing clinical practice guidelines.
- To describe the anticipated impact on hypertension management strategies.
Main Methods:
- Review of landmark hypertension trials (SPRINT, HOPE-3) and prior guidelines.
- Analysis of the implications for treatment thresholds and targets.
- Evaluation of effects on elderly populations and resistant hypertension management.
Main Results:
- SPRINT and HOPE-3 trials will likely alter hypertension management protocols.
- A shift towards automated blood pressure measurement is evident.
- Guidelines will be updated regarding treatment thresholds, targets, and special populations.
Conclusions:
- Recent hypertension research necessitates updates to clinical practice guidelines.
- Management strategies, including for resistant hypertension and the elderly, will evolve.
- Automated blood pressure monitoring is becoming standard in hypertension care.
Abstract:
Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with anti-hypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes. The recent trials SPRINT and HOPE-3 will lead to changes in the way we manage hypertension and impact on clinical practice guidelines. These studies also demonstrate the shift toward automated blood pressure measurements. We have reviewed these studies and others to put them in context with the guidelines that have come before and to describe how they will impact on hypertension treatment thresholds and targets, the treatment of hypertension in the elderly, and changing approaches to the management of hypertension including resistant hypertension.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology

